These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17538999)

  • 61. [Prediction of mycophenolic acid exposure in renal transplantation recipients by artificial neural network].
    Ren B; He QY; Xu Q; Wang CX; Chen J; Zheng ZH; Li SX; Chen X
    Yao Xue Xue Bao; 2009 Dec; 44(12):1397-401. PubMed ID: 21351476
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics of mycophenolic acid in living donor liver transplantation.
    Shin M; Moon JI; Kim JM; Choi GS; Kwon CH; Kim SJ; Joh JW; Lee SK; Lee ST; Jung H; Lee SY
    Transplant Proc; 2010 Apr; 42(3):846-53. PubMed ID: 20430188
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients.
    Lu XY; Huang HF; Sheng-Tu JZ; Liu J
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):885-91. PubMed ID: 16130190
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical Pharmacokinetics of Mycophenolic Acid in Hematopoietic Stem Cell Transplantation Recipients.
    Zhang D; Chow DS
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):183-189. PubMed ID: 27677732
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical mycophenolic acid monitoring in liver transplant recipients.
    Chen H; Chen B
    World J Gastroenterol; 2014 Aug; 20(31):10715-28. PubMed ID: 25152575
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Population pharmacokinetics of mycophenolic acid in lung transplant recipients with and without cystic fibrosis.
    Wang XX; Feng MR; Nguyen H; Smith DE; Cibrik DM; Park JM
    Eur J Clin Pharmacol; 2015 Jun; 71(6):673-679. PubMed ID: 25943384
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3 years posttransplant.
    Weber LT; Hoecker B; Armstrong VW; Oellerich M; Tönshoff B
    Ther Drug Monit; 2008 Oct; 30(5):570-5. PubMed ID: 18758392
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circadian variation of mycophenolate mofetil pharmacokinetics in rats.
    Dridi I; Ben-Cherif W; Aouam K; Ben-Attia M; Klouz A; Reinberg A; Boughattas NA
    Eur J Pharm Sci; 2014 Jul; 58():20-5. PubMed ID: 24657835
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short-term pharmacokinetic study of mycophenolate mofetil in neonatal swine.
    Pan H; Gazarian A; Fourier A; Gagnieu MC; Leveneur O; Sobh M; Michallet MC; Buff S; Roger T; Dubernard JM; Michallet M
    Transplant Proc; 2014 Dec; 46(10):3620-8. PubMed ID: 25498100
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Correlation of mycophenolic acid pharmacokinetic parameters with clinical events in kidney transplant patients treated with mycophenolate mofetil].
    Lin B; Zhu YC; Lu YP
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):251-3. PubMed ID: 19552842
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.
    Barau C; Furlan V; Debray D; Taburet AM; Barrail-Tran A
    Br J Clin Pharmacol; 2012 Sep; 74(3):515-24. PubMed ID: 22329639
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation.
    Jacobson P; Green K; Rogosheske J; Brunstein C; Ebeling B; DeFor T; McGlave P; Weisdorf D
    J Clin Pharmacol; 2007 Jan; 47(1):6-12. PubMed ID: 17192496
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Correlation between pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients.
    Minmin S; Zhidong G; Hao C; Weixia Z; Baiyong S; Bing C; Chuan S; Xiaxing D; Xi Z
    J Clin Pharmacol; 2010 Dec; 50(12):1388-96. PubMed ID: 20220042
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil.
    Zahr N; Arnaud L; Marquet P; Haroche J; Costedoat-Chalumeau N; Hulot JS; Funck-Brentano C; Piette JC; Amoura Z
    Arthritis Rheum; 2010 Jul; 62(7):2047-54. PubMed ID: 20506558
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intraocular availability of topically applied mycophenolate mofetil in rabbits.
    Knapp S; Bertelmann E; Hartmann C; Keipert S; Pleyer U
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):181-92. PubMed ID: 12804063
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The influence of norfloxacin and metronidazole on the disposition of mycophenolate mofetil.
    Naderer OJ; Dupuis RE; Heinzen EL; Wiwattanawongsa K; Johnson MW; Smith PC
    J Clin Pharmacol; 2005 Feb; 45(2):219-26. PubMed ID: 15647415
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil.
    Li H; Mager DE; Sandmaier BM; Maloney DG; Bemer MJ; McCune JS
    J Clin Pharmacol; 2013 Apr; 53(4):393-402. PubMed ID: 23382105
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A limited sampling model for estimation of total and unbound mycophenolic acid (MPA) area under the curve (AUC) in hematopoietic cell transplantation (HCT).
    Ng J; Rogosheske J; Barker J; Weisdorf D; Jacobson PA
    Ther Drug Monit; 2006 Jun; 28(3):394-401. PubMed ID: 16778725
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation.
    Kim H; Yi NJ; Lee J; Kim J; Moon MR; Jeong J; Lee JM; You TS; Suh SW; Park MS; Choi Y; Hong G; Lee HW; Lee KW; Suh KS
    Clin Mol Hepatol; 2014 Sep; 20(3):291-9. PubMed ID: 25320733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.